Neurocrine Biosciences Inc. (NBIX) Stock | Share Price | News

NBIX · Health Care · United States United States

Neurocrine Biosciences Inc. (NBIX) is a company in the Health Care sector, based in United States. The stock is held in 17 ETFs we track – with its largest weight of 0.23 % in XUHC (msci-usa-health-care). That means you can hold Neurocrine Biosciences indirectly and diversified through an ETF savings plan.

Above-average ETF coverage: 17 of the 95 ETFs we cover hold Neurocrine Biosciences, spread across 8 indices. That puts the stock in more ETFs than 78.0 % of the 4,362 stocks we cover.

Held in17 ETFs
Highest weight0.23 %
Indices8
SectorHealth Care
CountryUnited States
ISINUS64125C1099

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date+11.4 %1 year+14.4 %
1 month-11.2 %3 months+0.5 %
Calendar year 2025+3.9 %
Calendar year 2026+10.4 %
52W

Data note 3

Risk metrics

Max drawdown-42.9 %
Volatility p.a.37.0 %
Best year2026: +10.4 %
Worst year2025: +3.9 %

Data note 4

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Data note 5

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue2.9 bn $
Net income0.5 bn $
Diluted EPS4.67 $
Net margin16.7 %
Return on equity14.7 %
Equity ratio70.2 %
Revenue growth+21.4 %
Revenue and profit by fiscal year
Fiscal yearRevenueNet incomeMargin
FY20231.90.213.2 %
FY20242.40.314.5 %
FY20252.90.516.7 %

Data note 6

Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.

Held in these ETFs

Data note 7

Want to know how much Neurocrine Biosciences Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Neurocrine Biosciences — the figure counts the ETFs holding both.

Data note 8

Latest Investment Intelligence News: Stocks